ChemicalBook > Product Catalog >Analytical Chemistry >Standard >Pharmaceutical Impurity Reference Standards >(2S,4R)-5-(Biphenyl-4-yl)-4-[(tert-butoxycarbonyl)amino]-2-methylpentanoic acid
(2S,4R)-5-(Biphenyl-4-yl)-4-[(tert-butoxycarbonyl)amino]-2-methylpentanoic acid
- CAS No.
- 1012341-54-6
- Chemical Name:
- (2S,4R)-5-(Biphenyl-4-yl)-4-[(tert-butoxycarbonyl)amino]-2-methylpentanoic acid
- Synonyms
- LCZ704;LCZ696-18;LCZ696696-A-C;LCZ696 impuritiesF;LCZ 696 Impurity F;LCZ-696 Impurity 35;LCZ-696 Impurity 18;LCZ696 impurities126;Sacubitril Impurity 1;Sacubitril Impurity F
- CBNumber:
- CB02995775
- Molecular Formula:
- C23H29NO4
- Molecular Weight:
- 383.48
- MOL File:
- 1012341-54-6.mol
(2S,4R)-5-(Biphenyl-4-yl)-4-[(tert-butoxycarbonyl)amino]-2-methylpentanoic acid Preparation Products And Raw materials
Raw materials
Preparation Products
Global( 61)Suppliers
Supplier | Tel | Country | ProdList | Advantage | Inquiry |
---|---|---|---|---|---|
CLEARSYNTH LABS LTD. | +91-22-45045900 | Hyderabad, India | 6351 | 58 | Inquiry |
Pharmaffiliates Analytics and Synthetics P. Ltd | +91-172-5066494 | Haryana, India | 6773 | 58 | Inquiry |
BOC Sciences | +1-631-485-4226 | United States | 19553 | 58 | Inquiry |
China National Standard Pharmaceutical Corporation Limited | +8615391658522 | China | 11927 | 58 | Inquiry |
Guangzhou Tosun Pharmaceutical Limited | +8618922120635 | China | 1000 | 58 | Inquiry |
Amadis Chemical Company Limited | 571-89925085 | China | 131980 | 58 | Inquiry |
Anhui Feixiang Pharmaceutical Technology Co., Ltd. | 13349001619 | CHINA | 1007 | 58 | Inquiry |
Tianjin shijia biomedical technology co., LTD | 15022261580 | China | 2430 | 58 | Inquiry |
Energy Chemical | 021-58432009 400-005-6266 | China | 44843 | 58 | Inquiry |
Guangzhou Juntang Technology Co., Ltd | 020-36607679 13502246435 | China | 10951 | 58 | Inquiry |
1012341-54-6((2S,4R)-5-(Biphenyl-4-yl)-4-[(tert-butoxycarbonyl)amino]-2-methylpentanoic acid)Related Search:
LCZ696 interMediate
(S)-5-[(Biphenyl-4-yl)methyl]-1-(2,2-dimethylpropionyl)pyrrolidin-2-one
(2R,4S)-4-([1,1'-Biphenyl]-4-ylmethyl)-2-methyl-4-(2,5-dioxopyrrolidin-1-yl)butanoic acid
(2R,4S)-ethyl 5-([1,1'-biphenyl]-4-yl)-4-aMino-2-Methylpentanoate
((R)-2-biphenyl-4-yl-1-forMylethyl)carbaMic acid t-butyl ester
2-Pyrrolidinone, 5-([1,1'-biphenyl]-4-ylMethyl)-3-Methyl-, (3R,5S)-
(R,E)-ethyl 5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)aMino)-2-Methylpent-2-enoate
(2R,4S)-4-([1,1'-Biphenyl]-4-ylmethyl)-4-(4-ethoxy-4-oxobutanamido)-2-methylbutanoic acid
sacubitril
(2R,4S)-5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)aMino)-2-Methylpentanoic acid
chevron_left
1of4
chevron_right
(2S,4R)-5-(Biphenyl-4-yl)-4-[(tert-butoxycarbonyl)amino]-2-methylpentanoic acid
LCZ 696 Impurity F
LCZ704
(2S,4R)-5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpentanoic acid
LCZ696696-A-C
Sacubitril Impurity 1
(αS,γR)-γ-[[(1,1-Dimethylethoxy)carbonyl]amino]-α-methyl-[1,1-biphenyl]-4-pentanoic Acid
Sacubitril Impurity F
LCZ-696 Impurity 18
LCZ-696 Impurity 35
LCZ696-18
LCZ696(valsartan + sacubitril) impurity 19
1,1'-Biphenyl]-4-pentanoic acid, γ-[[(1,1-dimethylethoxy)carbonyl]amino]-α-methyl-, (αS,γR)-
-?biphenyl]?-?4-?pentanoicAcid
-?methyl-?[1,?1&rsquo
-?[[(1,?1-?Dimethylethoxy)?carbonyl]?amino]?-?&alpha
(αS,γR)-γ-[[(1,1-Dimethylethoxy)carbonyl]amino]-α-methyl[1,1'-biphenyl]-4-pentanoic acid
LCZ696 impurities126
LCZ696 impuritiesF
LCZ-696 Impurity 18(S,R)
Sabatrol calcium impurity 3
(2S,4R)-5-([1,1'-Biphenyl]-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpentanoic acid
1012341-54-6
LCZ696